Cyclerion Therapeutics, Inc. (CYCN) › Cash & EquivalentsCyclerion Therapeutics, Inc. (CYCN) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2019-12-31: $94.89M2020-12-31: $54.40M2021-12-31: $53.96M2022-12-31: $13.38M2023-12-31: $7.57M2024-12-31: $3.23M2025-12-31: $3.24M$3.24M2019-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$3.24M+0.2%2026-03-30Balance as of period end2024-12-31$3.23M-57.3%2026-03-30Balance as of period end2023-12-31$7.57M-43.4%2025-11-12Balance as of period end2022-12-31$13.38M-75.2%2024-03-05Balance as of period end2021-12-31$53.96M-0.8%2023-03-22Balance as of period end2020-12-31$54.40M-42.7%2022-02-24Balance as of period end2019-12-31$94.89M—2021-02-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)